Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -51.40% | 38.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -51.40% | 38.34% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -51.40% | 38.34% | |||
| SG&A Expenses | 11.59% | -52.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.23% | 21.12% | |||
| Operating Income | 3.97% | -19.27% | |||
| Income Before Tax | 4.52% | -10.29% | |||
| Income Tax Expenses | -- | -172.68% | |||
| Earnings from Continuing Operations | -2.38% | 6.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.38% | 6.68% | |||
| EBIT | 3.97% | -19.27% | |||
| EBITDA | 5.33% | -20.62% | |||
| EPS Basic | -2.01% | 6.75% | |||
| Normalized Basic EPS | 20.01% | -19.28% | |||
| EPS Diluted | -2.01% | 6.75% | |||
| Normalized Diluted EPS | 20.01% | -19.28% | |||
| Average Basic Shares Outstanding | 0.36% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||